ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PRVA vs ADUS // EV/EBITDA & P/E VALUATION

Privia Health Group Inc. (NASDAQ) VS. Addus HomeCare Corporation (NASDAQ) • 15-METRIC TALLY: PRVA 3 — ADUS 4
▲ EV/EBITDA & P/E VALUATION LEADER: ADUS
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PRVA VS. ADUS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PRVA ADUS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 32.50% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 10.50% 9.10% +1.40 PRVA /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 68.1x 16.8x +51.30 ADUS /valuation <GO>
Free Cash Flow Yield 5.82% 4.47% +1.35 PRVA /fcf-yield <GO>
Operating Margin — 9.70% — TIE /operating-margins <GO>
Net Profit Margin — 6.70% — TIE /net-margins <GO>
Revenue Growth (YoY) — 23.20% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 5.83 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 9/9 -3.00 ADUS /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 48.9 73.1 -24.20 ADUS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 114.0x 20.3x +93.70 ADUS /forward-pe <GO>
Enterprise Scale & Market Cap $2.81B $2.32B $487.6M PRVA /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PRVA REV ADUS REV PRVA GROSS % ADUS GROSS % PRVA FCF ADUS FCF
FY 2025 $0 $1.42B — 32.5% $163.4M $103.8M
FY 2024 $0 $1.15B — 32.5% $109.3M $110.4M
FY 2023 $0 $1.06B — — $80.8M $112.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PRVA // BETA —
ADUS // BETA —